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Abstract
Purpose The ventriculoperitoneal (VP) shunt has become the
procedure of choice for treatment of idiopathic intracranial
hypertension (IIH). We aimed to assess the efficacy of
frameless stereotactic placement of VP shunts for the manage-
ment of medically resistant IIH in children and to assess the
role of gender and obesity in the aetiology of the condition.
Methods This is a retrospective analysis of the case notes of
10 patients treated surgically at the University Hospital of
Wales in Cardiff, from May 2006 to September 2012.
Results VP shunts were successful in relieving headache,
papilloedema and stabilising vision. No sex predilection was
identified, and increased BMI was a feature throughout the
population, regardless of age.
Conclusions Neuronavigated VP shunt insertion is an effec-
tive mode of treatment for medically resistant IIH in children.
The aetiological picture in children does not seem to be dom-
inated by obesity, as in adults. Literature on childhood IIH is
sparse, and larger scale, comparative studies would be of ben-
efit to treating clinicians.
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Introduction
Ball et al. define idiopathic intracranial hypertension (IIH) as
‘the clinical syndrome of raised intracranial pressure in the
absence of space-occupying lesions, vascular lesions or en-
largement of the cerebral ventricles, for which no causative
factor can be identified’ [1, 2]. Furthermore, patients who
develop raised intracranial pressure (ICP) secondary to medi-
cations (e.g. doxycycline) or venous sinus stenoses are also
classified as IIH patients [3, 4].
Epidemiology and aetiology
Studies in North America have estimated that the incidence of
IIH is 0.9–1.0 per 100,000 in the general population [2]. It is
associated with female to male ratios ranging from 4:1 to 15:1
[4]. It is predominantly a condition of obese women of child-
bearing age, with an average age at diagnosis of 28.6 years [5,
6]. However, IIH also occurs in males, people of normal
weight and children [7]. The incidence of IIH in children is
unknown due to the approach of previous studies; paediatric
patients are typically mixed in within adult study populations,
and there is a lack of exclusion of patients for which secondary
aetiology was found [8–10]. Therefore, there is little evidence
to support the hypothesis that those risk factors associated
with IIH in adults hold true for paediatric patients.
Cinciripini et al. found that IIH in pre-pubertal children is rare,
that there was no sex predilection and that obesity was uncom-
mon [5].
Diagnosis and treatment
IIH is a syndrome characterised by the symptoms and signs of
raised ICP, e.g. headache and blurred vision with
papilloedema. The most frequent presenting symptom in
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children is headache [11, 12]. Visual disturbance is also com-
mon, with many patients developing transient visual obscura-
tions, blurring and/or progressive loss of peripheral vision.
These progressive ophthalmological problems are the
result of papilloedema and can lead to blindness if left
untreated. Less commonly, patients can present with
diplopia or pulsatile tinnitus [13]. Criteria for the diag-
nosis of IIH were originally proposed by Dandy [14] in
1937, revised by Friedman and Jacobson [2] in 2002
(Table 1).
Weight loss, discontinuation of precipitating drugs and
pharmacological management with acetazolamide (carbonic
anhydrase inhibitor) and other diuretics are the first line treat-
ments for IIH. Lumbar puncture aids diagnosis in addition to
therapeutically reducing ICP and providing symptom control.
Surgical intervention is typically reserved for those who re-
spond poorly to or fail to tolerate medical treatment or in those
whom vision is acutely deteriorating. The surgical interven-
tions employed to treat medically refractory IIH include optic
nerve fenestrat ion, ventr iculoperi toneal (VP) or
lumboperitoneal (LP) shunt insertion and intracranial venous
sinus stent deployment. Based on currently available evi-
dence, there is insufficient data to confidently recom-
mend or reject any of the surgical treatments modalities
for IIH [15].
Nevertheless, shunting procedures are most commonly
used, and provide rapid and effective reduction in intracranial
pressure. Lumboperitoneal shunts were previously favoured
as ventricles in IIH patients are often very small, making shunt
insertion difficult. However, LP shunts are associated with a
high complication rate [13] and with the development of
frameless stereotactic navigation (FSN), which has been
shown to increase the chances of optimal positioning of the
proximal catheter [9, 16, 17]; VP shunt insertion utilising FSN
has become the procedure of choice.
Materials and methods
Patients under the age of 18 years, who fulfilled the modified
Dandy criteria [14] for the diagnosis of IIH, that had under-
gone a neuronavigated VP shunt insertion at our institution
fromMay 2006 (when Stealth technology was acquired in our
department) to September 2012 (n = 10) were retrospectively
analysed. Intraoperative image guidance was achieved using a
wand-based navigation system (Stealth Station, Medtronic
Inc. ©). After the registration process, the target site for the
catheter was determined, with the Foramen of Munro used for
all cases, in line previous studies [18, 19]. The operative de-
tails of FSN-guided VP shunt insertion have been described
[9, 18, 19, 20]. A standard procedure for all 10 patients,
whereby a nine-gauge catheter with the stereotactic wand
inserted was advanced towards the target using image guid-
ance, was followed.
Data was collected regarding demographics, clinical pre-
sentation, details of treatment, alleviation of symptoms, oph-
thalmological examinations and length of follow-up.
When logging the visual acuity data, each eye of the 10
patients was analysed individually. LogMAR scores were
used to quantify visual acuity. When testing the acuity of
children, their score is dependent on co-operation during the
examination. To allow for this subjectivity, patients must re-
cord a difference of ≥0.2 on the LogMAR scale to be consid-
ered as having a significant change in their visual acuity.
The pre-operative visual acuity data for one patient (pa-
tient 10) could not be retrieved, and therefore, the pre to
post-operative difference could not be analysed. However,
in order to not discount this patient fully from our study,
and so that the procedure’s effect on visual acuity could be
assessed, three of the most recent visual acuity tests post-
operatively were analysed. This allowed us to gauge whether
this patient had achieved a degree of visual benefit from the
procedure.
BMI data was calculated for all 10 patients and was used to
identify a z-score. This enabled analysis based on the standard
deviation from the age-specific median weight for each pa-
tient. Using the World Health Organisation (WHO) BMI-for-
age criteria [21], it was identified whether the patient lay in the
category of obese (>98th percentile), overweight (91st-97th
percentile), normal weight (2nd-90th percentile), low weight
(1st-2nd percentile), or very low weight (<1st percentile).
Results
Six patients were male and four were female. Mean age
at diagnosis was 11.5 years (range 6–17). Follow-up
time ranged from 12 to 59 months, with a mean of
30.6 months (Table 2).
Table 1 Modified Dandy criteria for the diagnosis of IIH in both adults
and children as revised by Friedman and Jacobson [2, 14]
Modified Dandy criteria for the diagnosis of idiopathic intracranial
hypertension
1. If symptoms present, they may only reflect those of generalised
intracranial hypertension or papilloedema
2. If signs present, they may only reflect those of generalised intracranial
hypertension or papilloedema
3. Documented elevated intracranial pressure measured in the lateral
decubitus position
4. Normal CSF composition
5. No evidence of hydrocephalus, mass, structural or vascular lesion on
MRI or contrast-enhanced CT for typical patients, and MRI and MR
venography for all others
6. No other cause of intracranial hypertension identified
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Headache
All 10 patients reported headache pre-operatively. Eight
patients reported no headache at their most recent fol-
low-up.
Papilloedema
Nine patients (90%) had evidence of papilloedema at presen-
tation. Of these, eight (80%) had no evidence of papilloedema
post-operatively.
Visual acuity
The LogMAR scores for the patients whose pre- and post-
operative scores were available (n = 9) are displayed in
Table 3. Included in the table is an indication of whether the
visual acuity has improved (∧), deteriorated (∨) or remained
stable (–). When reading LogMAR data, it must be remem-
bered that a positive change in the score represents
deterioration in visual acuity whereas a negative change rep-
resents an improvement.
The visual deterioration seen in patient 7 was secondary to
multiple shunt malfunctions over a 4-month period. However,
once an effectively working shunt was in place, this patient’s
vision stabilised (Fig. 1).
The pre-operative LogMar score for patient 10 could not be
retrieved. However, the most recent three post-operative visu-
al acuity scores were used to assess the patient’s visual acuity.
These showed that the left eye had stabilised, but the right had
deteriorated (Fig. 2). This patient subsequently underwent ICP
monitoring which revealed normal ICP and therefore an ade-
quately functioning VP shunt.
Lumbar puncture opening pressure
Opening pressure readings from the patients’ pre-operative
lumbar punctures ranged from 35 to 75 cm H2O. The mean
value was 46.6 cm H2O. Indication of whether the visual
acuity has improved (∧), deteriorated (∨) or remained stable
(–) is shown (Table 4).
Body mass index
Data for the number of patients that fell into eachWHO BMI-
for-ageweight category is shown below (Fig. 3). Forty percent
of patients were classed as obese (n = 4); 30% were classed as
overweight (n = 3); ergo, 70% of the study population were
classed as above a normal weight category. Patients were also
split into 0–11 years (n = 5) and 12–17 years (n = 5) of age at
time of diagnosis. In both age categories, 40% of the patients
were obese (n = 2 in each age group). The younger age group
contained 40% within the normal weight category (n = 2),
whereas the older group contained only one child with a nor-
mal weight (20%; Fig. 2). No patients in the entire cohort had
low or very low weights.
Table 3 Data on pre- and post-operative visual acuities
Patient number Pre-operative Post-operative
Right eye Left eye Right eye Left eye
1 −0.18 −0.18 +0.00 – −0.18 –
2 +0.00 −0.04 −0.10 – +0.08 –
3 +0.00 +0.00 −0.08 – −0.08 –
4 +0.00 +0.00 +0.18 – +0.18 –
5 +0.12 +0.12 +0.00 – +0.00 –
6 +0.14 +0.14 +0.02 – +0.1 –
7 +0.30 +0.18 +1.60 ∨ +1.16 ∨
8 +0.30 +0.30 +0.00 ∧ +0.00 ∧
9 +0.30 +0.48 +0.48 – +0.65 –



















1 14 14 F Yes Yes No No Stable 27 59
2 11 11 M Yes No Yes No Stable 21 38
3 7 9 M Yes No Yes No Stable 21 36
4 17 17 F Yes No Yes No Stable 25 33
5 9 11 M Yes No Yes No Stable 18 34
6 12 12 M Yes Yes Yes No Stable 30 29
7 10 11 M Yes No Yes Yes Decreased 25 26
8 6 6 F Yes No Yes No Improved 14 23
9 12 12 M Yes No Yes No Stable 29 16
10 17 17 F Yes No Yes Yes Decreased in R eye,
stable in L
26 12
Childs Nerv Syst (2017) 33:1309–1315 1311
Discussion
This study of ten paediatric patients with IIH has assessed the
role of gender and obesity in the aetiology of the condition,
and provided outcome data supporting the efficacy of
frameless stereotactic placement of VP shunts for the manage-
ment of medically resistant IIH in children.
Demographics
The adult female sex predilection of IIH was not found in this
paediatric study, as 60% (n = 6) of patients were male. Other
studies have also failed to identify a clear female sex predilec-
tion in younger patients with paediatric IIH [1, 3, 4]. However,
the literature has identified that older children with IIH may
display associations with obesity and the female sex,
mirroring the established associations of adult IIH [3]. It has
tentatively been postulated that this difference in the demo-
graphics of paediatric IIH patients may be related to whether
patients are pre- or peri-pubertal. This notion is supported by a
number of case reports linking the onset and/or resolution of
paediatric IIH with imbalances in a variety of hormones, in-
cluding thyroid hormone, corticosteroids, oestrogens and
growth hormone [9]. Collating further evidence from larger
case series incorporating analysis of patients’ endogenous hor-
monal states could uncover whether there may be etiologically
distinct mechanisms underlying IIH, depending on whether
onset is prior to, during or post-pubertal [9, 10, 22].
Headache
Rangwala et al. state that headache is the single most common
complaint among children with idiopathic intracranial hyper-
tension and is present in 62–91% of cases [12]. This is
reflected in our study, with all patients reporting pre-shunt
headache. Eighty percent of patients (n = 8/10) described no
headache at their latest follow-up appointment.
Papilloedema
Nine (90%) of our patients had papilloedema pre-operatively,
and eight of these patients had no papilloedema at their most
Fig. 2 Line graph displaying post-operative LogMAR data for patient 10 for the latest three eye examinations post-shunt insertion. Visual acuity in the
left eye stabilised, whereas that of the right eye deteriorated, despite clinical confirmation of a functioning VP shunt. Blue line, right eye; red line, left eye
Fig. 1 Visual acuity for patient 7
post-operatively showing stable
vision once a functioning shunt
system was achieved (appoint-
ment 3). Blue line, right eye; red
line, left eye
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recent follow-up. The remaining patient showed improvement
but not complete resolution of papilloedema. It is, however,
recognised that some patients have continuing papilloedema
with a functioning shunt. Tulipan et al., for example, found
that 29% of their patients still showed evidence of
papilloedema post-shunt [20]. This may reflect the chronicity
of the condition in a sub-group of patients causing irreversible
damage to the optic nerve or be a consequence of continued
elevation of ICP, requiring further treatment. Meticulous fun-
doscopy is essential during post-operative follow-up to iden-
tify patients who may require further surgery as early as
possible.
Visual acuity
The decline in vision poses a significant problem in IIH, with
long-term consequences for the patient. Indeed, progressive
loss of vision is the principal criteria for surgical intervention.
Of the nine patients for whom we had paired pre- and post-
operative visual acuity data, visual acuity stabilised in both eyes
after shunt insertion in 89% of patients (n = 16/18 eyes).
One patient had a series of shunt malfunctions after inser-
tion that caused visual deterioration not noticed by the child or
parents. This was identified at his first clinical review post-
operatively at 3 months. His vision stabilised once an ade-
quately working shunt was established (Fig. 1). The one pa-
tient with only post-operative eye assessments showed im-
provement in the left eye but deterioration in the right eye,
even though her intracranial pressure was normal (Fig. 2).
This may be a consequence of severe, irreversible damage to
the optic nerve in this patient’s right eye pre-operatively.
Body mass index
In adults, there is a well-established association between obe-
sity and IIH [11]. The link between obesity and children with
Fig. 3 Data on the number of patients in each weight classification (n = 10)
Table 4 Pre-operative lumbar
puncture opening pressures,
alongside symptom improvement












35.0 Y Y – –
37.0 N N/A – –
39.5 Y Y – –
40.0 Y Y – –
40.0 N Y – –
40.0 Y Y – –
40.0 Y N N/A N/A
49.0 Y Y – –
70.0 Y Y ∧ ∧
75.0 Y N ∨ ∨
N/A not available
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IIH is less clear, and there are discrepancies in the literature
regarding this. When dealing with paediatric study popula-
tions, Babikian et al. found that 33% were obese [1], whereas
70% were obese in the study performed by Balcer et al. [3].
Though most studies agree that the role of obesity may not be
as pronounced as it is in adults [3], there is no consistent
quantification of the relationship between obesity and IIH in
children.
Balcer et al. separate their paediatric subject population
into tertiles by age in order to examine the relationship be-
tween IIH and obesity at varying ages. They found that older
children with IIH were more likely to be obese than younger
children—between the ages of 3–11 years, 41% of patients
were obese, whereas this number increased to 91% in the
15–17 years age group [3]. Balcer et al. state that in order to
discover the true aetiology, we must ‘examine the potential
roles of metabolic, hormonal, or other physiologic factors’
[3, 20].
In both age categories in our study (0–11 n = 5; 12–17,
n = 5), 40% of patients were obese. The younger age group
contained 40% within the ‘normal’ weight category, whereas
the older group contained only 20%. Only 40% of all patients
in the entire cohort were classed as ‘obese’. This study there-
fore echoes the suggestion postulated by previous works that
the role of obesity may not play as significant a role in the
paediatric population as it does in adult IIH. However, a fur-
ther 30% of the entire cohort (n = 3) was classed as ‘over-
weight’, resulting in a majority of our population (70%) being
classed as over the normal weight category. This may serve to
strengthen the hypothesis put forward by Daniels et al. that it
is not specifically obesity, but an absolute high BMI in general
which could be an important associated factor with paediatric
IIH [6].
LP opening pressure
The data on LP opening pressure failed to suggest a link be-
tween pre-operative pressure and the relief of either symptom
or papilloedema, although we appreciate that the numbers are
small.
Use of frameless stereotactic neuronavigation
Frameless stereotactic neuronavigation has been shown to im-
prove the chances of optimal placement of ventricular cathe-
ters when compared to conventional shunt surgery, with suc-
cessful ventricular cannulation typically reaching 100% when
the technology is utilised [9, 16, 18, 21]. Whilst its use may
slightly increase operative time [23], there appears to be no
difference in infection rates, and the revision rates are signif-
icantly lower than those for LP shunts [9, 23]. In one series of
paediatric patients with slit ventricles, the use of FSN aided
successful ventricular cannulation in 100% of the patient
cohort, with zero shunts requiring revisions at 8 months
post-operatively [8].
VP shunt revision rates after conventional shunt placement
procedures ranges between 30 and 50% at 24 months [18, 21,
23]. In a case series analysing FSN, revision rates were similar
or lower for patients with IIH (e.g. 30% at 49 months [9])
when compared to a series of conventionally inserted VP
shunts [9, 18, 21]. The important caveat here is that the his-
torical revision rate data is largely based upon blind cannula-
tion of hydrocephalic ventricles, as opposed to the more chal-
lenging slit-like ventricles typical of IIH. Furthermore, the
proportion of shunt revisions due to proximal catheter obstruc-
tion appears to be lower when FSN is used to aid insertion [18,
21]; distal obstruction/migration and under/overdrainage ap-
pear to account for the majority of shunt revision procedures
when FSN is used at the first operation.
In reviews of clinical effectiveness after FSN-guided VP
shunt insertion for IIH, significant improvements in headache,
stabilising vision and/or reduction in papilloedema, have been
reported [8, 16, 18, 21, 24]. These findings have been corrob-
orated by data from this study, which has also confirmed that
these improvements in headache and visual deterioration can
be sustained over longer follow-up periods (12–59 months)
than in previous series (8–9 months).
Study strengths and limitations
This is a retrospective case series of a rare condition. This is
illustrated clearly by the fact that in South Wales, there have
been only 10 paediatric cases requiring surgical treatment (VP
shunt insertion) during the 76-month study period. On review
of the literature, comparable studies involve very similar num-
bers, which are almost certainly a function of the relative rarity
of the condition in the paediatric population. For example, the
studies performed by Cinciripini et al. and Bynke et al. had
only 10 and 17 patients, respectively [2, 20, 25].
An established criterion for surgical intervention in paedi-
atric IIH is threat to, or deterioration of, vision in the presence
of failure of medical therapy [13, 15]. Our data identifies that
frameless navigated VP shunt insertion is an effective and safe
surgical option. The high rates of LP shunt failure and peri-
operative complications [24] therefore make stereotactic VP
shunting an attractive alternative method for CSF diversion in
IIH. Optic nerve fenestration remains another surgical option
in the management of severe visual loss in IIH. However, it
does not provide relief from headaches, and neither does it
guarantee preservation of vision [10, 12]. Most studies thus
far have focused on paediatric IIH case series’ outcomes after
optic nerve fenestration and LP shunting [9, 16, 17]. Our study
highlights the relative safety and effectiveness of image guid-
ed VP shunting in paediatric patients, and thus a comparison
of outcomes after stereotactic VP shunts and optic nerve fen-
estration in paediatric IIH is required.
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Conclusion
Frameless navigation for VP shunt placement is an effective
method of managing medication-resistant IIH in children for
both symptomatic relief and stabilisation of visual acuity. The
aetiological picture in the pubertal and post-pubertal paediatric
population is likely to be similar to that of adults with regard to
an association with an above-normal BMI. But this notion
falls short of the obesity-dominated aetiology that is well doc-
umented in the adult population, particularly in younger chil-
dren. The female sex predilection seen in adult patients does
not seem to be present in young children with IIH.
Furthermore, children often do not notice deterioration in their
vision, and therefore, the authors suggest early clinical and
ophthalmological reviews after shunt insertion to identify pos-
sible shunt malfunction.
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